Skip to main contentSkip to navigation
Sirius Investors

ELAB Stock: PMGC Holdings Inc. Stock Price, Analysis & Insights

Get live elab stock price $2.31, comprehensive PMGC Holdings Inc. stock analysis, charts, news, and expert forecast. Real-time elab stock data and investment insights.

2.31
29.68%Today
ELABPMGC Holdings Inc. • NASDAQ Capital Market • Healthcare
Market Cap
979.97K
Volume
8.80M
52W High
99.96
52W Low
2.10

Loading chart...

Company Overview

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

Company Information

CEO
Graydon Bensler
Sector
Healthcare
Industry
Biotechnology
Employees
2

Contact Information

Address
120 Newport Center Drive
Country
US

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 0.0)

Lower volatility stock (Beta: 0.30) may provide portfolio stability

Business Model & Strategy

PMGC Holdings Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Graydon Bensler, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.

Market Position & Competitive Landscape

PMGC Holdings Inc. competes in the Biotechnology within the broader Healthcare. With 979971 in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, PMGC Holdings Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating PMGC Holdings Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for PMGC Holdings Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for PMGC Holdings Inc.
  • Investors should consider how PMGC Holdings Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

979.97K

P/E Ratio

0.01

Beta

0.30

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 979.97K market capitalization
  • Trading Volume: 8.80M shares traded today
  • Price Range: 52-week range of $2.10 - $99.96
  • Exchange: Listed on NASDAQ Capital Market

Financial Metrics

P/E Ratio:0.01
EPS:$399.22
Beta:0.30
Avg Volume:566.55K

Market Analysis for PMGC Holdings Inc.

PMGC Holdings Inc. (ELAB) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 979.97K, the company represents a significant player in its market. The stock is currently trading at $2.31 with a negativedaily change of 29.68%.

The company's 2 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 0.01, beta of 0.30, and 52-week price range from $2.10 to $99.96when evaluating investment opportunities.

Why Invest in PMGC Holdings Inc.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Capital Market)
  • • Experienced leadership under Graydon Bensler
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.